MAVEN’S MISSION

MAVEN Diagnostic, Inc. utilizes patented, ultra sensitive, background free, nanocrystal-enable technology and proven assay protocols to manufacture rapid, field-deployable diagnostic tests that achieve near PCR sensitivity.  MAVEN is developing Rapid, Point-of-Care Antigen Test that directly measure specific proteins from the novel coronavirus in less than 15 minutes. Our goal is to develop reliable diagnostic results to allow medical professionals to make confident decisions to quaratine, treat or allow access to people.
Beyond addressing the COVID-19 pandemic, MAVEN aims to develop a full suite of tests to identify a broad spectrum of infectious diseases and be ready to conduct endemic testing for the next outbreak.